Trial Details
COMPLETEDBasic Information
| Clinical ID | c1162 |
|---|---|
| Identifier | NCT04231110 |
| Trial Title | Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: Fecal microbiota transplantation |
Participant Information
| Sponsor | McMaster University |
|---|---|
| City | Hamilton |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2021-05-01 |
|---|---|
| Primary Completion Date | 2024-11-18 |
| Completion Date | 2024-11-18 |